Zydus Lifesciences appoints Swati Dalal as ZHL managing director

Zydus Lifesciences (BSE: 532321) has announced the appointment of Ms. Swati Dalal (DIN: 01513751) as the Additional Director and Managing Director of its wholly owned subsidiary, Zydus Healthcare Limited (ZHL). The appointment, effective June 16, 2025, is for a term of five years and was approved by the Nomination and Remuneration Committee (NRC) and the Board of Directors. Ms. Dalal, a seasoned commercial leader with over 30 years of experience, previously held leadership roles at Abbott. She will form a part of the Senior Management of the Company. The appointment complies with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as detailed in the company's filing.